Fulcrum Equity Management »

Adma Biologics shares owned by Fulcrum Equity Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Fulcrum Equity Management from 13F filings

Historical chart of Fulcrum Equity Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Fulcrum Equity Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Fulcrum Equity Management

Quarter filed Position value Share count Share price at filing
2026-09-30 $128k 13k 10.03

More positions owned by Fulcrum Equity Management

Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Msci World Etf (URTH)
Select Sector Spdr Tr St Str Techn Etf (XLK)
NVIDIA Corporation (NVDA)
Oneok (OKE)
Spdr Series Trust St Str P500etf (SPYM)
Apple (AAPL)
Select Sector Spdr Tr St Str Finl Etf (XLF)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)
Select Sector Spdr Tr St Str Indl Etf (XLI)
Select Sector Spdr Tr St Str Care Etf (XLV)

View all positions for Fulcrum Equity Management

Top funds holding Adma Biologics

BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
Rubric Capital Management
Capital Research Global Investors
First Trust Advisors
Geode Capital Management
Caligan Partners
D. E. Shaw & Co
Dimensional Fund Advisors
Goldman Sachs Group
Nuveen
Duquesne Family Office
Northern Trust

View all funds holding Adma Biologics